Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer

被引:56
|
作者
Zhou, Yujuan
Liao, Qianjin
Han, Yaqian
Chen, Jie
Liu, Zhigang
Ling, Hang
Zhang, Jing
Yang, Wenjuan
Oyang, Linda
Xia, Longzheng
Wang, Li
Wang, Heran
Xue, Lei
Wang, Hui [1 ,2 ]
Hu, Bingqiang [1 ,2 ]
机构
[1] Cent South Univ, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
来源
JOURNAL OF CANCER | 2016年 / 7卷 / 14期
基金
中国国家自然科学基金;
关键词
non-small cell lung cancer; Rac1; epithelial-mesenchymal transition; prognosis; markers; radiotherapy; POTENTIAL THERAPEUTIC TARGET; RADIORESISTANT HEAD; GAMMA-IRRADIATION; INHIBITION; EXPRESSION; INVASION; REARRANGEMENTS; METASTASIS; STATISTICS; CARCINOMA;
D O I
10.7150/jca.16198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Ras-related C3 botulinum toxin substrate1(Rac1) and epithelial mesenchymal transition (EMT) are key therapeutic targets in cancer. We investigated the clinical significance of Rac1 and markers of EMT expression in non-small cell lung cancer (NSCLC), and their possible correlation with EMT phenotype. Methods: Immunohistochemistry was used to assess the expression of Rac1, Snail1, Twist1, N-cadherin (N-cad), Vimentin (Vim), and E-cadherin (E-cad) in 153 NSCLC paraffin-embedded specimens and 45 normal specimens adjacent to tumors. The correlation of Rac1 and EMT markers with clinicopathological characteristics and the relationship between the protein levels and progression-free survival (PFS) and overall survival (OS) were analyzed. Results: Compared with non-tumor tissues, the NSCLC tissues showed marked elevation in the levels of Rac1, Snail1, Twist1, N-cad, and Vim levels, whereas the E-cad levels were significantly decreased (P < 0.05). The aberrant expression of Rac1 and EMT markers was significantly associated with TNM stage and metastasis (P < 0.05). Increased expression of Rac1 may be associated with poor OS and PFS compared with low expression (P<0.001 and P=0.004). Significant correlations were observed between the EMT markers expressed and OS or PFS(P<0.01). In addition, multivariate analysis indicated that the expression of Rac1, Snail1, Twist1, N-cad, Vim, and E-cad was an independent prognostic factor in NSCLC. Interestingly, Rac1 expression was positively correlated with Snail1, Twist1, N-cad, and Vim levels (r=0.563, r=0.440, r=0.247 r=0.536, P<0.01, respectively) and negatively correlated with E-cad levels (r=-0.464, P<0.001) in NSCLC tissues. Rac1, Twist, Snail1, Vim and N-cad were highly expressed in lung cancer patients resistant to radiotherapy, while E-cad was poorly expressed. Conclusion: Rac1 may promote NSCLC progression and metastasis via EMT, which may be considered as a potential therapeutic target.
引用
收藏
页码:2100 / 2109
页数:10
相关论文
共 50 条
  • [31] MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer
    Wang, Yu-zhou
    Wu, Kun-peng
    Wu, Ai-bing
    Yang, Zhi-cheng
    Li, Jin-mei
    Mo, Yan-li
    Xu, Meng
    Wu, Bin
    Yang, Zhi-xiong
    [J]. TUMOR BIOLOGY, 2014, 35 (10) : 9815 - 9821
  • [32] Overexpression of immunohistochemical RhoA associated with poor prognosis in operable non-small cell lung cancer
    Lou, Ming
    Gao, Zhao-Jia
    Zhu, Tao
    Mao, Xiao-Liang
    Yuan, Kai
    Tong, Ji-Chun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06): : 7577 - 7584
  • [33] OVEREXPRESSION OF AB-CRYSTALLIN PREDICTS POOR PROGNOSIS IN NON-SMALL-CELL LUNG CANCER
    Gu, Jie
    Ge, Di
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S452 - S452
  • [34] Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
    J S Keum
    G Kong
    S C Yang
    D H Shin
    S S Park
    J H Lee
    J D Lee
    [J]. British Journal of Cancer, 1999, 81 : 127 - 132
  • [35] Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer
    Kong, Fei-Fei
    Qu, Zeng-Qiang
    Yuan, Hai-Hua
    Wang, Jiong-Yi
    Zhao, Mei
    Guo, Yue-Hui
    Shi, Jing
    Gong, Xiao-Di
    Zhu, You-Long
    Liu, Feng
    Zhang, Wen-Ying
    Jiang, Bin
    [J]. ONCOLOGY REPORTS, 2014, 31 (06) : 2660 - 2668
  • [36] Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer
    Gu, Jie
    Ding, Jian-yong
    Lu, Chun-lai
    Lin, Zong-wu
    Chu, Yi-wei
    Zhao, Guang-yin
    Guo, Jing
    Ge, Di
    [J]. LUNG CANCER, 2013, 81 (02) : 259 - 265
  • [37] Overexpression of galectin-1 indicates poor prognosis in resected non-small cell lung cancer patients
    Zhou, Ping
    Yu, He
    Li, Weimin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (12): : 12519 - 12526
  • [38] Epithelial-mesenchymal transition changes in smokers with non-small cell lung cancer
    Lu, W.
    Chia, C.
    Larby, J.
    Haug, G.
    Hardikar, A.
    Singhera, G.
    Hackett, T.
    Robertson, I
    Eapen, M.
    Sohal, S.
    [J]. RESPIROLOGY, 2023, 28 : 56 - 57
  • [39] Effect of AXL on the epithelial-to-mesenchymal transition in non-small cell lung cancer
    Ying, Xueming
    Chen, Jun
    Huang, Xueming
    Huang, Peng
    Yan, Shaocong
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 785 - 790
  • [40] Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity to Chemoradiotherapy in Non-Small Cell Lung Cancer
    Shintani, Yasushi
    Okimura, Akira
    Sato, Katsutoshi
    Nakagiri, Tomoyuki
    Kadota, Yoshihisa
    Inoue, Masayohi
    Sawabata, Noriyoshi
    Minami, Masato
    Ikeda, Naoki
    Kawahara, Kunimistu
    Matsumoto, Tomoshige
    Matsuura, Nariaki
    Ohta, Mitsunori
    Okumura, Meinoshin
    [J]. ANNALS OF THORACIC SURGERY, 2011, 92 (05): : 1794 - 1804